학술논문
Report of the ISTH registry on pregnancy and COVID-19-associated coagulopathy (COV-PREG-COAG).
Document Type
Article
Author
Source
Subject
*HEMORRHAGE complications
*PREGNANCY
*BLOOD coagulation disorders
*VEINS
*QUESTIONNAIRES
*FISHER exact test
*INTERNATIONAL agencies
*SEVERITY of illness index
*DESCRIPTIVE statistics
*POSTPARTUM hemorrhage
*CHI-squared test
*PREGNANCY outcomes
*CONTENT mining
*THROMBOEMBOLISM
*COVID-19
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1753-495X
Abstract
Background: Concerns about COVID-19-associated coagulopathy (CAC) in pregnant individuals were raised in early pandemic. Methods: An ISTH-sponsored COVID-19 coagulopathy in pregnancy (COV-PREG-COAG) international registry was developed to describe incidence of coagulopathy, VTE, and anticoagulation in this group. Results: All pregnant patients with COVID-19 from participating centers were entered, providing 430 pregnancies for the first pandemic wave. Isolated abnormal coagulation parameters were seen in 20%; more often with moderate/severe disease than asymptomatic/mild disease (49% vs 15%; p < 0.0001). No one met the ISTH criteria for disseminated intravascular coagulopathy (DIC), though 5/21 (24%) met the pregnancy DIC score. There was no difference in antepartum hemorrhage (APH) with asymptomatic/mild disease versus moderate/severe disease (3.4% vs 7.7%; p = 0.135). More individuals with moderate/severe disease experienced postpartum hemorrhage (PPH) (22.4% vs 9.3%; p = 0.006). There were no arterial thrombotic events. Only one COVID-associated venous thromboembolism (VTE) was reported. Conclusions: Low rates of coagulopathy, bleeding, and thrombosis were observed among pregnant people in the first pandemic wave. [ABSTRACT FROM AUTHOR]